Table of Contents

Chapter 1: Principles of Surgical Oncology

Chapter 2: Principles of Radiation Therapy

Chapter 3: Principles of Oncologic Pharmacotherapy

Chapter 4: Head and Neck Tumors

Chapter 5; Thyroid and Parathyroid Cancers

Chapter 6: Non-Small-Cell Lung Cancer

Chapter 7: Small-Cell Lung Cancer, Mesothelioma, and Thymoma

Chapter 8: Breast Cancer Overview

Chapter 9: Stages 0 and I Breast Cancer

Chapter 10: Stage II Breast Cancer

Chapter 11: Stages III and IV Breast Cancer

Chapter 12: Esophageal Cancer

Chapter 13: Gastric Cancer

Chapter 14: Pancreatic, Neuroendocrine GI, and Adrenal Cancers

Chapter 15: Liver, Gallbladder, and Biliary Tract Cancers

Chapter 16: Colon, Rectal, and Anal Cancers

Chapter 17: Prostate Cancer

Chapter 18: Testicular Cancer

Chapter 19: Urothelial and Kidney Cancers

Chapter 20: Cervical Cancer

Chapter 21: Uterine Corpus Tumors

Chapter 22: Ovarian Cancer

Chapter 23: Melanoma and Other Skin Cancers

Chapter 24: Bone Sarcomas

Chapter 25: Soft-Tissue Sarcomas

Chapter 26: Primary and Metastatic Brain Tumors

Chapter 27: AIDS-related Malignancies

Chapter 28: Carcinoma of an Unknown Primary Site

Chapter 29: Hodgkin Lymphoma

Chapter 30: Non-Hodgkin Lymphoma

Chapter 31: Multiple Myeloma and Other Plasma Cell Dysrasias

Chapter 32: Acute Leukemias

Chapter 33: Chronic Myeloid Leukemia

Chapter 34: Chronic Lymphocytic Leukemia

Chapter 35: Myelodysplastic Syndromes

Chapter 36: Hematopoietic Cell Transplantation

Chapter 37: Pain Management

Chapter 38: Management of Nausea and Vomiting

Chapter 39: Depression, Anxiety, and Delirium

Chapter 40: Hematopoietic Growth Factors

Chapter 41: Fatigue and Dyspnea

Chapter 42: Anorexia and Cachexia

Chapter 43: Long-term Venous Access

Chapter 44: Oncologic Emergencies and Paraneoplastic Syndromes

Chapter 45: Infectious Complications

Chapter 46: Fluid Complications

Color atlas 1: The ABCDEs of moles and melanomas

Color atlas 2: Skin lesions

Color atlas 3: Dermatologic toxicities associated with targeted therapies

Appendix 1: Response Evaluation Criteria and Performance Scales

Appendix 2: Cancer Information on the Internet

Appendix 3: Cancer Drugs and Indications Newly Approved by the US Food and Drug Administration

Appendix 4: Chemotherapeutic Agents Their Uses, Dosages, and Toxicites
News & News Analysis

Duration of tamoxifen use influences cancer risk in opposite breast
Oncology NEWS International,  October 15, 2009
Low-risk tumors exhibit high proliferation index
Oncology NEWS International,  October 15, 2009
Bayer Taps New CEO
Oncology NEWS International,  October 15, 2009
Adjuvant Rx yields minor benefit in less aggressive colon cancer
Oncology NEWS International,  October 15, 2009
Low expression of MSH2 protein predicts survival in NSCLC
Oncology NEWS International,  September 29, 2009

 

Order Your Copy!